Text and Data Mining valid from 2018-10-12
Received: 6 June 2018
Revised: 27 August 2018
Accepted: 3 September 2018
First Online: 12 October 2018
Compliance with ethical standards
: Y-TT declares that she has no conflict of interest. KCA is the scientific founder of Oncopep and C4 Therapeutics and serves on the advisory boards of MedImmune, Bristol-Myers Squibb, Gilead and Millenium Pharmaceuticals. PWH is an employee of Spirogen and has stock and/or stock interests in AstraZeneca. All other authors are employees of MedImmune or were employees of MedImmune while they were involved with this work and have stock and/or stock interests in AstraZeneca.